Nexus NeuroTech Ventures

Nexus NeuroTech Ventures is a venture capital firm founded in 2023 that invests in early-stage to growth-stage companies developing technologies for diagnosis, treatment, or management of brain disorders. The firm has raised $126 million to support its mission and backs innovations spanning medical devices (including both invasive and non-invasive), software diagnostics, data platforms for clinical trials/care management, and digital health tools. Its initial focus includes Parkinson’s disease, bipolar disorder, autism spectrum disorder, essential tremor, ADHD/developmental delays—supporting both hardware/software solutions with promising human data.